MEPs Slate EU Industry Practices In Report On Barriers To Medicines Access
Executive Summary
The European Parliament’s environment and public health committee has produced a set of recommendations for a new approach to tackling barriers to medicines in the EU. There’s a particular focus on pricing strategies, intellectual property, and delays to generic competition.